Optimal Fasting Glucose Range for Lowest CVD Risk
For adults with no significant medical history, the fasting glucose range associated with the lowest cardiovascular disease risk is 85-99 mg/dL, with levels below 75 mg/dL or above 100 mg/dL conferring increased cardiovascular risk. 1, 2
Evidence-Based Glucose Thresholds
The most robust evidence comes from a prospective cohort study of over 1.1 million Koreans followed for 16 years, which demonstrated J-shaped curves for CVD risk with the nadir at 85-99 mg/dL 1. This finding is corroborated by an urban population study showing fasting glucose <75 mg/dL was associated with the lowest prevalence of cardiovascular risk factors including hypertension, dyslipidemia, and metabolic syndrome 2.
Risk at Lower Glucose Levels
- Fasting glucose <70 mg/dL increases stroke risk by 6% in men (HR 1.06) and 11% in women (HR 1.11) 1
- Levels <70 mg/dL confer a 3.3-fold increased risk of cardiovascular mortality, and 70-79 mg/dL carries a 2.4-fold increased risk compared to 80-109 mg/dL 3
- This U-shaped relationship persists even after adjusting for age, smoking, hypertension, cholesterol, BMI, and prior cardiovascular disease 3
Risk at Higher Glucose Levels
- As fasting glucose increases >100 mg/dL, risks for CVD, ischemic heart disease, myocardial infarction, and thrombotic stroke progressively increase 1
- The relationship between fasting glucose and cardiovascular risk factors shows a continuous trend, with each increment above 75 mg/dL associated with higher prevalence of hypertension, obesity, hypercholesterolemia, and metabolic syndrome 2
Post-Prandial Glucose Matters More Than Fasting
A critical caveat from the ESC/EASD guidelines: post-load (2-hour) glucose is a stronger predictor of CVD mortality than fasting glucose alone 4. The DECODE study of over 22,000 Europeans demonstrated that:
- High 2-hour post-load glucose predicted all-cause, CVD, and CAD mortality after adjustment for other risk factors, but high fasting glucose alone did not 4
- Impaired glucose tolerance (IGT) doubled CVD mortality, while isolated impaired fasting glucose showed no significant increase in mortality 4
- The relationship between 2-hour glucose and mortality was linear, but no such linear relation existed with fasting glucose 4
Clinical Application Algorithm
Step 1: Assess fasting glucose in context
- Target range: 85-99 mg/dL for lowest CVD risk 1
- If <75 mg/dL: investigate for hypoglycemia causes, consider increased stroke risk 1, 2
- If 100-125 mg/dL: recognize progressive CVD risk increase 1
Step 2: Don't rely on fasting glucose alone
- Obtain 2-hour post-load glucose or consider continuous glucose monitoring, as post-prandial hyperglycemia is the stronger CVD predictor 4
- The largest absolute number of excess CVD deaths occurs in subjects with IGT who have normal fasting glucose 4
Step 3: Address modifiable risk factors
- Optimal fasting triglyceride level may be ≤100 mg/dL, as observational studies consistently show lowest CVD risk at the lowest triglyceride levels 4
- The 25% rise in U.S. triglyceride levels over recent decades coinciding with higher caloric intake represents a reversible CVD risk factor 4
Common Pitfalls
Pitfall 1: Assuming "normal" fasting glucose is safe
- Standard laboratory reference ranges (70-100 mg/dL) include the upper range where CVD risk begins to increase 1
- Even fasting glucose of 90-109 mg/dL carries higher risk than 85-99 mg/dL 1
Pitfall 2: Ignoring low glucose levels
- Clinicians often focus only on hyperglycemia, but fasting glucose <70 mg/dL significantly increases cardiovascular and all-cause mortality 3
- This is not simply a marker of frailty—the association persists after extensive multivariate adjustment 3
Pitfall 3: Overlooking post-prandial glucose